Pre-Cure is transforming cancer treatment selection through a predictive, biopsy-based platform built on 3D tumoroids – miniature models of each patient’s own tumor.
By evaluating their individual response, our drug-prioritization test pinpoints the therapies most likely to work, supporting the right treatment from the very first line.